ReachMD

Be part of the knowledge.™

Oncology and Hematology

1816

LikeLikedUnlike

Episodes 1-15 of 493

- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
1
CME/CE
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
- Joshua Bauml, MD
  Peer
0
Closing the Gaps in NSCLC
Mechanisms of Acquired Resistance to Targeted Therapies in NSCLC
- Joshua Bauml, MD
  Peer
0
Closing the Gaps in NSCLC
RET Fusions vs. RET Point Mutations: Understanding the Difference
- Mario R. Nacinovich, Jr., MSc
  Peer
- Lyudmila Bazhenova, MD
  Peer
0
Closing the Gaps in NSCLC
Targeting Oncogenic Drivers in NSCLC: Opportunities & Challenges
- Joshua Bauml, MD
  Peer
0
Closing the Gaps in NSCLC
What to Consider When Testing for Oncogenic Drivers in NSCLC
- Joshua Bauml, MD
  Peer
0
Closing the Gaps in NSCLC
How COVID-19 Has Impacted the Care Continuum for NSCLC Patients
- Peter O'Donnell, MD
  Peer
3
Medical Industry Feature
Urothelial Carcinoma: Case Study on a Patient Who Is Cisplatin Ineligible
- Joshua Bauml, MD
  Peer
0
Closing the Gaps in NSCLC
Exploring RET-Targeted Cancer Diagnosis & Treatment Strategies
- Jennifer Caudle, DO
  Peer
- Mikkael A. Sekeres, MD, MS
  Peer
- Sara M. Tinsley, PhD, ARNP, AOCNP
  Peer
0
CME/CE
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylati...
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, DO, MS
  Peer
0
CME/CE
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Tr...
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
3
CME/CE
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
2
CME/CE
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
- William D. Tap, MD
  Peer
- John Healey, MD
  Peer
3
CME/CE
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
2
CME/CE
Keeping Pace: The Role of Immunotherapy After Disease Progression
- Bora Lim, M.D.
  Peer
0
Breaking Boundaries in Breast Cancer
Identifying Barriers in Breast Cancer Care & Where Further Research Is Needed

Loading...

Programs 8/8/20

Segment Chapters

Playlist:

Recommended